MHRA-2022-0048-V148

Type II variation for application MHRA-2022-0048. Type II variation: Shelf Life Extension for Crizotinabex — routine update

Variation Number
MHRA-2022-0048-V148
Type
Type II
Application
MHRA-2022-0048
Change
CHG-2021-0148
Status
Approved
Fee
€20,136
Submitted
2024-04-28
Approved
2023-09-03
Description

Type II variation: Shelf Life Extension for Crizotinabex — routine update